TA
Trevor Allred Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ligand Pharmaceuticals
LGND
$3.25B
| $166.75 | $190 |
14%
upside
| Outperform | 4 days ago |
|
2
Innoviva
INVA
$1.29B
| $20.48 | $35 |
71%
upside
| Outperform | 27 days ago |
|
|
MBX
3
MBX Biosciences, Inc. Common Stock
MBX
$388M
| $11.55 | $38 |
229%
upside
| Outperform | 1 month ago |
|